
- IREDA Q2 FY27 Results: How Did the Company Perform?
- Why Did IREDA's Profit Grow Just 1% Despite Higher Revenue?
- Are IREDA's Bad Loans Still a Concern?
- Why Is IREDA Share Price Under Pressure After Q2 Results?
- What Should IREDA Investors Watch After Q2 FY27 Results?
- IREDA Q2 Results: Should Investors Be Worried?
IREDA Q2 Results Explained: Why Is Profit Growth Slow Despite Rising Loans?
IREDA's Q2 FY27 results reveal an interesting gap between business growth and profitability. The renewable energy lender reported a 31% rise in loan disbursements and 14% revenue growth, yet its net profit increased by just 1% to ₹554 crore.
At the same time, bad loans declined, suggesting an improvement in asset quality. So, why isn't IREDA's growing lending business generating stronger profits?
The answer lies in rising financing costs, higher provisions for potential loan losses and the challenge of maintaining profitability while expanding. With IREDA shares under pressure, these results deserve a closer look.
IREDA Q2 FY27 Results: How Did the Company Perform?
Indian Renewable Energy Development Agency (IREDA), a government-owned renewable energy financier, announced its September-quarter results on October 19, 2026.
The company reported growth in lending, revenue and net worth. However, profit growth remained considerably slower.
| Financial metric | Q2 FY26 | Q2 FY27 | YoY change |
| Revenue from operations | ₹2,057 Cr | ₹2,345 Cr | +14% |
| Net profit (PAT) | ₹549 Cr | ₹554 Cr | +1% |
| Loan disbursements | ₹8,062 Cr | ₹10,579 Cr | +31% |
| Outstanding loan book | ₹84,477 Cr | ₹97,411 Cr | +15% |
| Net worth | ₹12,920 Cr | ₹14,337 Cr | +11% |
| Gross NPA | 3.97% | 3.57% | Improved |
| Net NPA | 1.97% | 1.08% | Improved |
Three things stand out.
First, IREDA continues to expand its lending business. Loan disbursements rose 31%, indicating healthy financing activity.
Second, the outstanding loan book increased 15% to ₹97,411 crore. This matters because the outstanding balance, rather than new disbursements alone, determines how much money IREDA can earn interest on.
Third, despite expanding its business, the company generated only about ₹5 crore more profit than a year earlier.
There is, however, a positive development. IREDA's profit recovered from approximately ₹337 crore in Q1 FY27 to ₹554 crore in Q2, an increase of around 64% sequentially.
Therefore, the results do not show a business in continuous decline. They show a lender recovering from a weak previous quarter while still struggling to improve profits compared with last year.
Why Did IREDA's Profit Grow Just 1% Despite Higher Revenue?
To understand this, we need to look at how IREDA makes money.
IREDA provides loans to renewable energy businesses, including solar, wind and other clean-energy projects. It earns interest on these loans, but it also borrows money to fund its lending operations.
Its profitability depends on how much interest remains after paying borrowing costs and covering potential losses from borrowers who may not repay.
Here's what happened in Q2.
| Financial metric | Q2 FY26 | Q2 FY27 |
| Interest income | ₹2,030 Cr | ₹2,317 Cr |
| Finance costs | ₹1,213 Cr | ₹1,376 Cr |
| Impairment charges | ₹70 Cr | ₹187 Cr |
| Net profit | ₹549 Cr | ₹554 Cr |
1. Financing costs increased alongside lending income
IREDA earned approximately ₹287 crore more in interest income compared with the previous year. However, it also spent about ₹164 crore more on financing costs.
That is partly how a lending business works. To finance more projects, IREDA generally needs access to additional funds, which carry interest expenses. The important question is whether the returns earned on loans are growing faster than the cost of funding them.
In IREDA's case, interest income minus finance costs increased from approximately ₹817 crore to ₹940 crore, a rise of around 15%. This suggests the company's core interest-earning business improved. Higher financing expenses alone do not establish that its lending margins are deteriorating.
In fact, IREDA reported a net interest margin (NIM) of 3.83%. NIM measures how much interest income a lender retains after borrowing costs, relative to its interest-earning assets.
2. Provisions absorbed much of the additional income
This is where the results become more interesting. IREDA's impairment charges increased from approximately ₹70 crore to ₹187 crore.
Impairment charges are amounts recognised in the profit and loss statement for expected losses on loans and other financial assets. They reduce reported profit, although they do not necessarily represent cash lost during that quarter.
Consider the numbers:
- Interest income after finance costs increased by approximately ₹123 crore.
- Impairment charges increased by approximately ₹117 crore.
In other words, the additional credit-loss charges absorbed most of the improvement in net interest income.
Other income, operating costs, exchange-related items and taxes also affect the final profit figure, but impairment was a major reason for the disconnect.
There is some relief when comparing Q2 with Q1. Impairment charges declined from approximately ₹419 crore in the June quarter to ₹187 crore in September. That reduction helped IREDA recover its quarterly profit.
IREDA's core lending income is growing, but credit costs are making its earnings less predictable. Investors should focus on whether these charges continue declining or remain elevated as lending expands.
Are IREDA's Bad Loans Still a Concern?
This is arguably the most encouraging part of IREDA's Q2 results.
The company's gross non-performing asset (NPA) ratio declined to 3.57% from 3.97% a year earlier. Net NPA fell more sharply, from 1.97% to 1.08%.
Net NPA also improved from 1.23% in the June 2026 quarter.
An NPA is a loan that has stopped performing as expected, generally because repayments are overdue.
The lower these ratios, the smaller the proportion of reported loans that are classified as problematic.
IREDA's provision coverage ratio on Stage III loans also improved from 51.48% to 70.44%. This indicates that the company has recognised provisions against a larger share of these impaired loans.
However, improving ratios do not mean credit risk has disappeared.
IREDA's disclosures include fraud-related borrower exposures totalling ₹672.74 crore, including loans associated with Gensol Engineering and Gensol EV Lease. The company reported making full expected-credit-loss provisions for these accounts and initiating recovery proceedings.
Importantly, the ₹672.74 crore figure represents disclosed exposures, not an entirely new loss recognised in Q2.
The audit disclosures also highlight loans amounting to approximately ₹386.76 crore where classification considerations are affected by interim court orders. This is relevant when interpreting reported asset quality, although it does not automatically mean an equivalent additional loss will arise.
The auditors issued an unmodified opinion.
The broader point is that renewable energy financing carries project-specific risks. Delays in commissioning, cash-flow difficulties or repayment problems at individual borrowers can affect a lender's earnings.
IREDA's improving NPA ratios are encouraging. But the relatively high impairment charges show why investors cannot rely on NPA percentages alone to judge the health of its loan book.
Why Is IREDA Share Price Under Pressure After Q2 Results?
IREDA's share price had already been under pressure before the latest earnings announcement.
The stock closed at ₹106.54 on October 19, 2026, and was trading around ₹103 during the October 21 session, close to its 52-week low.
The results were announced after market hours on October 19, meaning that day's decline should not be attributed to the announcement. The subsequent weakness also needs to be viewed alongside broader market movements.
So, what might concern investors?
The first issue is earnings growth. A lender with a rapidly expanding loan book can attract investor interest, but sustained share-price gains ultimately need support from earnings and returns on shareholder capital.
The second issue is consistency. IREDA's quarterly profit has recovered substantially, but its year-on-year profit growth remains almost flat.
The third is valuation.
At a share price around ₹103 and net worth of approximately ₹14,337 crore, IREDA was valued at roughly twice its book value.
For a financing company, price-to-book (P/B) is a useful metric because it compares the company's market valuation with its accounting net worth. But a lower share price or P/B ratio does not automatically make a lender undervalued.
For example, a business that consistently earns strong returns on its equity and keeps bad loans under control may justify a higher valuation. Conversely, weaker earnings or recurring loan losses can reduce what investors are willing to pay.
For IREDA, the question is not simply whether its share price has fallen enough. It is whether future profit growth and asset quality can support the valuation.
What Should IREDA Investors Watch After Q2 FY27 Results?
IREDA's latest results leave investors with both encouraging developments and unanswered questions.
| What could improve the outlook? | What could weaken it? |
| Continued growth in the outstanding loan book | Loan growth slowing despite strong disbursements |
| Stable or improving net interest margins | Rising funding costs relative to lending returns |
| Further reduction in impairment charges | Fresh bad loans or higher provisions |
| Continued improvement in NPAs | Recovery difficulties in stressed accounts |
| Stronger profits and return on equity | Profit growth remaining below loan growth |
One particularly important metric is the relationship between loan growth and impairment charges.
For illustration, suppose IREDA increases its annual average loan book by ₹10,000 crore. At an assumed 3.8% net interest margin, that additional lending could contribute approximately ₹380 crore in annual net interest income before operating expenses, credit losses and taxes.
This is an illustrative calculation, not company guidance or a profit forecast. Actual outcomes would depend on funding costs, loan yields, timing and asset quality.
It demonstrates why loan growth is valuable only when a sufficient portion of the additional income reaches the bottom line.
The next few quarters will therefore be important in showing whether IREDA can sustain lending growth while keeping impairment charges under control.
IREDA Q2 Results: Should Investors Be Worried?
IREDA's Q2 FY27 results do not indicate that its growth story has stopped. Loan disbursements are increasing, the outstanding loan book is expanding and reported asset quality has improved.
The concern is profitability.
Despite healthy growth in interest income, higher impairment charges meant that net profit increased by only 1% year-on-year.
There is also reason for cautious optimism. Quarterly profit has recovered sharply, and both gross and net NPA ratios are moving in a favourable direction.
The key test for IREDA is whether this recovery can become consistent profit growth.
For investors tracking IREDA shares, rising loan disbursements alone will not be enough. The more meaningful signs will be stable lending margins, fewer credit losses and stronger returns on the capital used to finance India's renewable energy expansion.